X2HN37B
Insertion Ventricle, Left to New Technology Group 11 with Endocardiac Pacing Electrode, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | H Insertion |
| Body Part | N Ventricle, Left |
| Approach | 3 Percutaneous |
| Device | 7 Endocardiac Pacing Electrode |
| Qualifier | B New Technology Group 11 |
Operation Definition
Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part
Procedure Overview
This family covers implanting a nonbiological device into the heart or a blood vessel that monitors or supports a physiological function without replacing any tissue itself. A common example is a leadless cardiac pacemaker, a self-contained capsule placed directly inside a heart chamber through a catheter rather than through a surgically implanted pulse generator with wire leads. The device senses the heart's electrical activity and delivers pacing impulses as needed, addressing slow or irregular heart rhythms.
Because the New Technology section exists to track devices recently approved for distinct reimbursement and outcomes monitoring, these procedures are typically newer catheter-based alternatives to long-established open or lead-based techniques. Patients considering them are often candidates who face higher risk from traditional lead placement, such as those with prior infections or difficult venous access.
Anatomy & Axis Detail
Ventricle, Left
The left ventricle is the heart's dominant pumping chamber, generating the pressure needed to circulate blood throughout the entire body, and its thick, muscular wall reflects that workload. Devices inserted into this chamber are typically positioned to support, monitor, or otherwise assist its pumping function, and placement must account for the mitral and aortic valve apparatus, the papillary muscles, and the chamber's conical geometry to avoid disrupting normal flow or valve closure. Access may be obtained retrograde across the aortic valve or via a transseptal approach through the atrial septum, and the chosen route affects both procedural risk and how the device is ultimately positioned. Because the left ventricle bears primary responsibility for systemic perfusion, any device situated here is closely tied to therapies aimed at supporting or evaluating overall cardiac output.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Endocardiac Pacing Electrode
This value identifies the pacing electrode component situated within the heart chamber itself, as used in leadless pacemaker systems that eliminate transvenous leads. It differs from conventional endocardial leads by being self-contained and fixed directly to the myocardium without a separate generator connection running through a vein. The device is typically paired with related components like an ultrasound transmitter for cross-chamber communication.
Qualifier: New Technology Group 11
This qualifier designates Group 11, the most recent cohort at the time of its introduction, grouping technologies newly approved for New Technology section reporting in that fiscal year. Like every group value in this axis, it functions as an administrative marker rather than a description of the clinical intervention, which is captured elsewhere in the code. Its main point of confusion is with Group 10, the immediately preceding annual release.
Coding & Documentation
Coders need the operative note to confirm the specific brand or device named in the New Technology table entry, since these codes are device-specific rather than generic. Documentation should state the approach (typically percutaneous), the target chamber, and confirmation that the device itself performs the monitoring or assistive function rather than serving as a structural replacement. A frequent error is defaulting to the standard Cardiovascular section code for pacemaker or device insertion instead of checking whether the specific model qualifies for a New Technology designation, which can materially change reimbursement. Another common miss is failing to update code selection when a device's New Technology group value changes between annual code set updates.
Commonly Confused With
This is easily confused with standard Insertion procedures coded in the regular Cardiovascular System section, where the distinguishing factor is solely whether the device brand appears in the New Technology reference table for that year. It is also distinct from Replacement, which applies when the device or material takes over the physical role of a body part rather than simply monitoring or assisting it.